Diagnostic criteria for dementia in clinical trials - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

被引：0
|
作者：
Antuono, P
Doody, R
Gilman, S
Huff, J
Scheltens, P
Ueda, K
Khachaturian, ZS
机构：
[1] ALZHEIMERS ASSOC, RONALD & NANCY REAGAN RES INST, POTOMAC, MD 20854 USA
[2] BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA
[3] UNIV MICHIGAN, MED CTR, DEPT NEUROL, ANN ARBOR, MI 48109 USA
[4] HOECHST MARION ROUSSEL INC, NEUROSCI RES, BRIDGEWATER, MA USA
[5] FREE UNIV AMSTERDAM HOSP, DEPT NEUROL, NL-1007 MB AMSTERDAM, NETHERLANDS
来源：
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 1997年 / 11卷
关键词：
Alzheimer disease; clinical trials; criteria; diagnosis; international standardization;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Some of the issues associated with standardizing the diagnosis of dementia in clinical trials are outlined. Deliberations of the Working Group on Diagnostic Criteria and their recommendations for future actions needed to develop a consensus are described.
引用
收藏
页码：22 / 25
页数：4
相关论文
共 50 条
  • [1] Length of clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Levy, R
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 33 - 33
  • [2] Translation issues in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Feldman, H
    Anand, R
    Blesa, R
    Dubois, B
    Gray, J
    Homma, A
    Mohr, E
    Morris, JC
    Parys, W
    Raschig, A
    Robillard, A
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 61 - 64
  • [3] Clinical trials of treatment for noncognitive symptoms of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Homma, A
    Brodaty, H
    Bruno, G
    Cummings, JL
    Gilman, S
    Gracon, S
    McKeith, IG
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 54 - 55
  • [4] Clinical global measures of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Reisberg, B
    Schneider, L
    Doody, R
    Anand, R
    Feldman, H
    Haraguchi, H
    Kumar, R
    Lucca, U
    Mangone, CA
    Mohr, E
    Morris, JC
    Rogers, S
    Sawada, T
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 8 - 18
  • [5] Objective psychometric tests in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Ferris, SH
    Lucca, U
    Mohs, R
    Dubois, B
    Wesnes, K
    Erzigkeit, H
    Geldmacher, D
    Bodick, N
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 34 - 38
  • [6] Ethical issues in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Post, SG
    Beerman, B
    Brodaty, H
    Gaines, AW
    Gauthier, SG
    Geldmacher, DS
    Hill, S
    Homma, A
    Rossor, MN
    Whitehouse, PJ
    Winblad, B
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 26 - 28
  • [7] Activities of daily living as an outcome measure in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Gauthier, S
    Bodick, N
    Erzigkeit, E
    Feldman, H
    Geldmacher, DS
    Huff, J
    Mohs, R
    Orgogozo, JM
    Rogers, S
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 6 - 7
  • [8] Issues in the economic evaluation of treatment for dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Winblad, B
    Hill, S
    Beermann, B
    Post, SG
    Wimo, A
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 39 - 45
  • [9] Quality-of-life assessment in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Whitehouse, PJ
    Orgogozo, JM
    Becker, RE
    Gauthier, S
    Pontecorvo, M
    Erzigkeit, H
    Rogers, S
    Mohs, RC
    Bodick, N
    Bruno, G
    DalBianco, P
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 56 - 60
  • [10] Prevention protocols for Alzheimer disease - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Thal, LJ
    Carta, A
    Doody, R
    Leber, P
    Mohs, R
    Schneider, L
    Shimohama, S
    Silber, C
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 46 - 49
12345